The protective effects of nucleotides on the histamine hypersensitivity of Bordetella pertussis-treated mice.
D000244:Adenosine Diphosphate / Q000627:therapeutic use; D000249:Adenosine Monophosphate / Q000627:therapeutic use; D000255:Adenosine Triphosphate / Q000009:adverse effects / Q000627:therapeutic use; D000707:Anaphylaxis / Q000517:prevention & control*; D000818:Animals; D001886:Bordetella pertussis / Q000276:immunology*; D003994:Bucladesine / Q000627:therapeutic use; D003345:Corticosterone / Q000627:therapeutic use; D000242:Cyclic AMP / Q000627:therapeutic use; D006152:Cyclic GMP / Q000627:therapeutic use; D003854:Deoxyribonucleotides / Q000627:therapeutic use; D005260:Female; D006632:Histamine; D006969:Hypersensitivity, Immediate / Q000517:prevention & control*; D007003:Hypoglycemia / Q000209:etiology; D007292:Inosine Nucleotides / Q000627:therapeutic use; D051379:Mice; D009711:Nucleotides / Q000627:therapeutic use*; D011453:Prostaglandins / Q000627:therapeutic use; D013154:Spleen / Q000276:immunology; D013942:Thymine Nucleotides / Q000627:therapeutic use; D013950:Thymus Gland / Q000276:immunology; D013997:Time Factors
D003854:Deoxyribonucleotides; D007292:Inosine Nucleotides; D009711:Nucleotides; D011453:Prostaglandins; D013942:Thymine Nucleotides; D000249:Adenosine Monophosphate; D000244:Adenosine Diphosphate; D003994:Bucladesine; D006632:Histamine; D000255:Adenosine Triphosphate; D000242:Cyclic AMP; D006152:Cyclic GMP; D003345:Corticosterone